These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 35601411)

  • 1. Pediatric Moyamoya Disease and Syndrome in Italy: A Multicenter Cohort.
    Po' C; Nosadini M; Zedde M; Pascarella R; Mirone G; Cicala D; Rosati A; Cosi A; Toldo I; Colombatti R; Martelli P; Iodice A; Accorsi P; Giordano L; Savasta S; Foiadelli T; Sanfilippo G; Lafe E; Thyrion FZ; Polonara G; Campa S; Raviglione F; Scelsa B; Bova SM; Greco F; Cordelli DM; Cirillo L; Toni F; Baro V; Causin F; Frigo AC; Suppiej A; Sainati L; Azzolina D; Agostini M; Cesaroni E; De Carlo L; Di Rosa G; Esposito G; Grazian L; Morini G; Nicita F; Operto FF; Pruna D; Ragazzi P; Rollo M; Spalice A; Striano P; Skabar A; Lanterna LA; Carai A; Marras CE; Manara R; Sartori S
    Front Pediatr; 2022; 10():892445. PubMed ID: 35601411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct Clinical and Radiographic Phenotypes in Pediatric Patients With Moyamoya.
    Kaseka ML; Slim M; Muthusami P; Dirks PB; Westmacott R; Kassner A; Bhathal I; Williams S; Shroff M; Logan W; Moharir M; MacGregor DL; Pulcine E; deVeber GA; Dlamini N
    Pediatr Neurol; 2021 Jul; 120():18-26. PubMed ID: 33962345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between moyamoya disease and moyamoya syndrome in Israel.
    Schwartzmann Y; Spektor S; Moscovici S; Jubran H; Metanis I; Jouaba T; Cohen JE; Gomori JM; Leker RR
    J Stroke Cerebrovasc Dis; 2024 Apr; 33(4):107635. PubMed ID: 38342272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical outcomes following encephaloduroarteriosynangiosis in North American adults with moyamoya.
    Agarwalla PK; Stapleton CJ; Phillips MT; Walcott BP; Venteicher AS; Ogilvy CS
    J Neurosurg; 2014 Dec; 121(6):1394-400. PubMed ID: 25280094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative clinical symptomatology and stroke burden in pediatric moyamoya angiopathy: Defining associated risk variables.
    Hackenberg A; Battilana B; Hebeisen M; Steinfeld R; Khan N
    Eur J Paediatr Neurol; 2021 Nov; 35():130-136. PubMed ID: 34715507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moyamoya Disease and Syndrome: A National Inpatient Study of Ischemic Stroke Predictors.
    Unda SR; Antoniazzi AM; Miller R; Klyde D; Javed K; Fluss R; Holland R; De la Garza Ramos R; Haranhalli N; Altschul DJ
    J Stroke Cerebrovasc Dis; 2021 Sep; 30(9):105965. PubMed ID: 34247053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natural clinical course of hemodynamically stable adult moyamoya disease.
    Cho WS; Chung YS; Kim JE; Jeon JP; Son YJ; Bang JS; Kang HS; Sohn CH; Oh CW
    J Neurosurg; 2015 Jan; 122(1):82-9. PubMed ID: 25361479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of surgical revascularization for stroke prevention in pediatric patients with sickle cell disease and moyamoya syndrome.
    Yang W; Xu R; Porras JL; Takemoto CM; Khalid S; Garzon-Muvdi T; Caplan JM; Colby GP; Coon AL; Tamargo RJ; Huang J; Ahn ES
    J Neurosurg Pediatr; 2017 Sep; 20(3):232-238. PubMed ID: 28686127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features, surgical treatment and long-term outcome in adult patients with Moyamoya disease in China.
    Bao XY; Duan L; Li DS; Yang WZ; Sun WJ; Zhang ZS; Zong R; Han C
    Cerebrovasc Dis; 2012; 34(4):305-13. PubMed ID: 23146868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical Treatment for Patients with Moyamoya Syndrome and Type 1 Neurofibromatosis.
    Porras JL; Yang W; Garzon-Muvdi T; Xu R; Blakeley J; Belzberg A; Caplan JM; Khalid S; Colby GP; Coon AL; Tamargo RJ; Ahn ES; Huang J
    World Neurosurg; 2017 Mar; 99():19-25. PubMed ID: 27876659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and long-term outcomes of moyamoya syndrome associated with neurofibromatosis type 1.
    Han C; Yang WZ; Zhang HT; Ye T; Duan L
    J Clin Neurosci; 2015 Feb; 22(2):286-90. PubMed ID: 25443089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China.
    Liu XJ; Zhang D; Wang S; Zhao YL; Teo M; Wang R; Cao Y; Ye X; Kang S; Zhao JZ
    J Neurosurg; 2015 Feb; 122(2):392-9. PubMed ID: 25423267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of and Risk Factors for Cerebral Microbleeds in Moyamoya Disease and Syndrome in the American Population.
    Khan NI; Saherwala AA; Chen M; Salehian S; Salahuddin H; Welch BG; Pinho MC; Shang T
    Cerebrovasc Dis Extra; 2019; 9(3):139-147. PubMed ID: 31830749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. dl-3-n-butylphthalide for alleviation of neurological deficit after combined extracranial-intracranial revascularization for moyamoya disease: a propensity score-matched analysis.
    Li Z; Lu J; Ma L; Wu C; Xu Z; Chen X; Ye X; Wang R; Zhao Y
    J Neurosurg; 2019 Feb; 132(2):421-433. PubMed ID: 30771781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moyamoya disease versus moyamoya syndrome: comparison of presentation and outcome in 338 hemispheres.
    Feghali J; Xu R; Yang W; Liew JA; Blakeley J; Ahn ES; Tamargo RJ; Huang J
    J Neurosurg; 2019 Oct; 133(5):1441-1449. PubMed ID: 31585423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anesthetic challenges in pediatric moyamoya disease: A report of two cases.
    Bhatnagar V; Kulkarni SN; Sharma A; Dolla SB
    Brain Circ; 2020; 6(1):47-51. PubMed ID: 32166200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral revascularization surgery reduces cerebrovascular events in children with sickle cell disease and moyamoya syndrome: Results of the stroke in sickle cell revascularization surgery retrospective study.
    Aldana PR; Hanel RA; Piatt J; Han SH; Bansal MM; Schultz C; Gauger C; Pederson JM; Iii JCW; Hulbert ML; Jordan LC; Qureshi A; Garrity K; Robert AP; Hatem A; Stein J; Beydler E; Adelson PD; Greene S; Grabb P; Johnston J; Lang SS; Leonard J; Magge SN; Scott A; Shah S; Smith ER; Smith J; Strahle J; Vadivelu S; Webb J; Wrubel D
    Pediatr Blood Cancer; 2023 Jul; 70(7):e30336. PubMed ID: 37057741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of more than 20 years of follow-up in pediatric patients with moyamoya disease undergoing pial synangiosis.
    Riordan CP; Storey A; Cote DJ; Smith ER; Scott RM
    J Neurosurg Pediatr; 2019 Mar; 23(5):586-592. PubMed ID: 30835683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stroke prevention by direct revascularization for patients with adult-onset moyamoya disease presenting with ischemia.
    Kim T; Oh CW; Kwon OK; Hwang G; Kim JE; Kang HS; Cho WS; Bang JS
    J Neurosurg; 2016 Jun; 124(6):1788-93. PubMed ID: 26636391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Encephaloduroarteriosynangiosis for pediatric moyamoya disease: long-term follow-up of 100 cases at a single center.
    Zhang Y; Bao XY; Duan L; Yang WZ; Li DS; Zhang ZS; Han C; Zhao F; Zhang Q; Wang QN
    J Neurosurg Pediatr; 2018 Aug; 22(2):173-180. PubMed ID: 29856299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.